COMMUNIQUÉS West-GlobeNewswire
-
Procedure of the Annual General Meeting
09/10/2025 -
Nurix Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update
09/10/2025 -
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
09/10/2025 -
Executive Wellness Retreats: Grey Matters International Announces Expansion of Neuroscience-Based Programs
09/10/2025 -
Academy Award-Winning Actress Helen Hunt to Headline Methodist Healthcare Foundation Luncheon
09/10/2025 -
Smith+Nephew announces new category I CPT® code for its CARTIHEAL™ AGILI-C™ Cartilage Repair Implant
09/10/2025 -
Childhood Cancer Deserves Year-Round Commitment to Funding and Research
09/10/2025 -
JOURTHON® Launches Brain Health Softgel
09/10/2025 -
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
09/10/2025 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of September 30, 2025
09/10/2025 -
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2025
09/10/2025 -
Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting
09/10/2025 -
Idorsia launches an offering of registered shares – to fund the company to overall profitability
09/10/2025 -
ICPO Foundation welcomes 24 new ICPO Theranostics Clinical Centers of Excellence to its global network of 45 centers
09/10/2025 -
CERTIFIED Opens First Columbus Dispensary, Revives Local Landmark with Drive-Thru Cannabis Experience
09/10/2025 -
Editas Medicine Reports In Vivo Proof-of-Concept Data for EDIT-401 at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress
09/10/2025 -
Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data at the American Academy of Ophthalmology (AAO) 2025 Annual Meeting, October 18-21 in Orlando
09/10/2025 -
Applications Now Open for Fall 2025 First Practice Fund Scholarship
09/10/2025 -
Fifty 1 Labs Inc. Appoints Dr. Joel Gagnier as Chief Science Officer
09/10/2025
Pages